IP Library Granted Patent US 12,201,356
Granted Patent B2
US 12,201,356 · App. 17/246,174 · Granted Jan 21, 2025

Dual wavelength laser ablation systems for MRI-guided ablation procedures and related devices and methods

Inventors: Christine Drown (Louisville, CO); Rebecca Vincelette (Louisville, CO); Roopali Shah (Louisville, CO); Nicole Barney (Louisville, CO); Benjamin Ewing (Louisville, CO)
Assignee: Medtronic Navigation, Inc.
A61B18/20A61B18/22A61B2017/0023A61B2018/00005A61B2018/00577A61B2018/00642A61B2018/00702A61B2018/00791A61B2018/207A61B2034/2051
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,201,356
App. No.
17/246,174
Granted
Jan 21, 2025
Kind
B2
Abstract

Laser ablation devices and related systems and methods may have laser outputs with multiple wavelengths. Laser ablation devices may include a laser energy source that can emit two or more laser outputs with different wavelengths. Some laser ablation devices include a processor to control the laser energy source to cause the laser energy source to emit a target wavelength blend with the laser outputs.

Claims (40)

1. A laser ablation system comprising:

a laser energy source configured to emit two or more laser outputs with different wavelengths;

a laser applicator coupled to the laser energy source via a laser fiber, the laser applicator to output laser radiation at a tissue of an ablation site; and

a processor to:

monitor temperatures across tissue zones of the tissue at the ablation site, the tissue zones of the tissue at the ablation site comprising a target ablation zone and a protected area tissue zone, wherein the target ablation zone comprises a target tissue to be ablated, and wherein the protected area tissue zone comprises tissue that is not to be ablated; and

control the laser energy source to emit at least one laser output of the two or more laser outputs to apply thermal energy across the ablation site using the different wavelengths, wherein emitted laser outputs are chosen based on a wavelength and current monitored temperatures across each of the tissue zones of the tissue at the ablation site.

2. The laser ablation system of claim 1 , wherein the two or more laser outputs comprise a first laser output with a wavelength of 980 nm and a second laser output with a wavelength of 1064 nm.

3. The laser ablation system of claim 2 , wherein the processor causes the laser energy source to emit a greater amount of the second laser output than the first laser output when a center part of the tissue at the ablation site approaches a maximum target temperature before an outer part of the tissue at the ablation site reaches a minimum target temperature.

4. The laser ablation system of claim 2 , wherein the two or more laser outputs further comprise a third laser output with a wavelength of 800 nm.

5. The laser ablation system of claim 1 , wherein the two or more laser outputs have wavelengths between 800 nm and 1310 nm.

6. The laser ablation system of claim 1 , wherein the processor is further to determine a blend of the two or more laser outputs to apply thermal energy across the ablation site based on the current monitored temperatures across each of the tissue zones of the tissue at the ablation site.

7. The laser ablation system of claim 1 , wherein the processor is further to cause the laser energy source to:

emit an initial low power dose of laser energy; and

determine a blend of the two or more laser outputs to apply thermal energy across the ablation site based on a thermal response of the tissue at the ablation site to the initial low power dose of laser energy emitted.

8. The laser ablation system of claim 1 , wherein the processor is further to choose the emitted laser outputs based on a target lesion size and feedback received during a procedure, the feedback comprising at least one of a progress of ablation towards a surgical target and a target thermal radiation pattern.

9. The laser ablation system of claim 1 , wherein the two or more laser outputs comprise a first laser output with a first wavelength and a second laser output with a second wavelength, wherein the processor causes the laser energy source to emit the first laser output in on and off pulses having a first duty cycle and emit the second laser output in on and off pulses having a second duty cycle.

10. The laser ablation system of claim 9 , wherein the first duty cycle is longer than the second duty cycle.

11. The laser ablation system of claim 9 , wherein the processor causes the laser energy source to emit the on and off pulses having the first duty cycle alternatively to the on and off pulses having the second duty cycle.

12. The laser ablation system of claim 11 , wherein the processor causes the laser energy source to:

monitor a reaction of the tissue at the ablation site in response to emission of the first laser output at the first wavelength and the second laser output at the second wavelength; and

adjust at least one of a power, duration, and selection of a next laser output wavelength based on the reaction monitored.

13. The laser ablation system of claim 12 , wherein the reaction of the tissue at the ablation site is a thermal relaxation time of the tissue at the ablation site.

14. A laser ablation method, comprising:

inserting a laser applicator into a desired region of treatment comprising a tissue of an ablation site;

emitting, by a laser energy source configured to emit two or more laser outputs with different wavelengths, a laser energy to apply thermal energy at the tissue of the ablation site;

monitoring, by a processor, temperatures across tissue zones of the tissue at the ablation site, the tissue zones of the tissue at the ablation site comprising a target ablation zone and a protected area tissue zone, wherein the target ablation zone comprises a target tissue to be ablated, and wherein the protected area tissue zone comprises tissue that is not to be ablated; and

controlling, by the processor, the laser energy source to emit at least one laser output of the two or more laser outputs to apply thermal energy across the ablation site using the different wavelengths, wherein the at least one laser output emitted is chosen based on a wavelength and current monitored temperatures across each of the tissue zones of the tissue at the ablation site.

15. The laser ablation method of claim 14 , wherein the two or more laser outputs comprise a first laser output with a wavelength of 980 nm and a second laser output with a wavelength of 1064 nm.

16. The laser ablation method of claim 15 , further comprising:

controlling, by the processor, the laser energy source to emit a greater amount of the second laser output than the first laser output when a center part of the tissue at the ablation site approaches a maximum target temperature before an outer part of the tissue at the ablation site reaches a minimum target temperature.

17. The laser ablation method of claim 14 , wherein prior to emitting the laser energy, the laser ablation method further comprises:

causing, by the processor, the laser energy source to emit an initial low power dose of laser energy; and

determining, by the processor and based on a thermal response of the tissue at the ablation site to the initial low power dose of laser energy, a blend of the two or more laser outputs to apply the thermal energy across the ablation site.

18. A non-transitory computer-readable medium including instructions that when executed by one or more processors of a tissue ablation system cause the tissue ablation system to:

monitor temperatures across tissue zones of tissue at an ablation site, the tissue zones of the tissue at the ablation site comprising a target ablation zone and a protected area tissue zone, wherein the target ablation zone comprises a target tissue to be ablated, and wherein the protected area tissue zone comprises tissue that is not to be ablated; and

control a laser energy source that is configured to emit two or more laser outputs with different wavelengths to emit, from a laser applicator coupled to the laser energy source, at least one laser output of the two or more laser outputs to apply thermal energy across the ablation site using the different wavelengths, wherein the at least one laser output emitted is chosen based on a wavelength and current monitored temperatures across each of the tissue zones of the tissue at the ablation site.

19. The non-transitory computer-readable medium including instructions of claim 18 , wherein the instructions are further to cause the tissue ablation system to cause the laser energy source to emit a greater amount of a second laser output of the two or more laser outputs than a first laser output of the two or more laser outputs when a center part of the tissue at the ablation site approaches a maximum target temperature before an outer part of the tissue at the ablation site reaches a minimum target temperature, and wherein the first laser output comprises a wavelength of 980 nm and the second laser output comprises a wavelength of 1064 nm.

20. The non-transitory computer-readable medium including instructions of claim 18 , wherein prior to the instructions are further to cause the tissue ablation system to:

emit an initial low power dose of laser energy; and

determine a blend of the two or more laser outputs to apply thermal energy across the ablation site based on a thermal response of the tissue at the ablation site to the initial low power dose of laser energy emitted.

Assignments (2)
MERGER Recorded Oct 22, 2024
From: VISUALASE INC.
To: MEDTRONIC NAVIGATION, INC.
Reel/Frame 068967/0888 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 2, 2021
From: DROWN, CHRISTINE; VINCELETTE, REBECCA; SHAH, ROOPALI; BARNEY, NICOLE; EWING, BENJAMIN
To: MEDTRONIC NAVIGATION, INC.
Reel/Frame 056748/0269 →
Continuity (2)
Provisional Application 63019810 · May 4, 2020
Related Publication 20210338328A1 · Nov 4, 2021
References Cited (17)
US 6056741A · Van Saarloos · 2000 [cited by applicant]
US 8876810B2 · Neuberger · 2014 [cited by applicant]
US 10251703B2 · Albeck et al. · 2019 [cited by applicant]
US 10285758B2 · Rink et al. · 2019 [cited by applicant]
US 20060116669A1 · Dolleris · 2006 [cited by examiner]
US 20090248004A1 · Altshuler et al. · 2009 [cited by applicant]
US 20120232534A1 · Rink · 2012 [cited by examiner]
US 20130190742A1 · Connors et al. · 2013 [cited by applicant]
US 20140147802A1 · Naldoni · 2014 [cited by applicant]
US 20150182283A1 · Boutoussov · 2015 [cited by applicant]
US 20180140866A1 · Daly et al. · 2018 [cited by applicant]
US 20180214204A1 · Karmarkar · 2018 [cited by examiner]
US 20180310988A1 · Panescu · 2018 [cited by examiner]
EP 1958584 · 2008 [cited by applicant]
WO 2008153999 · 2008 [cited by applicant]
WO 2018115410 · 2018 [cited by applicant]
International Search Report and Written Opinion dated Aug. 16, 2021 for PCT/US2021/030292. [cited by applicant]